# Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation

> **NCT00426595** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 14 (estimated)

## Conditions studied

- Gastreoesophageal Reflux Disease

## Interventions

- **DRUG:** Administration of omeprazole suspension
- **DRUG:** omeprazole administered as a multi-unit-pellet system

## Key facts

- **NCT ID:** NCT00426595
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2009-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426595, "Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00426595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*